| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |